Publication Venue For
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
Short Communication: Apoptotic Membrane Microparticles Quantified by Fluorescent Bead-Based Assay Are Elevated in HIV and SIV Infections.
HIV Self-Testing in Lusaka Province, Zambia: Acceptability, Comprehension of Testing Instructions, and Individual Preferences for Self-Test Kit Distribution in a Population-Based Sample of Adolescents and Adults.
Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming.
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.
HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation.
Associations between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy among Patients Living with HIV.
Duration of Influenza Virus Shedding among HIV-Infected Adults in the cART Era, 2010-2011.
Increased Steady-State Memory B Cell Subsets among High-Risk Participants in an HIV Vaccine Trial.
Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients.
Complement component 3 is associated with metabolic comorbidities in older HIV-positive adults.
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function.
Obesity is Associated with Race/Sex Disparities in Diabetes and Hypertension Prevalence, but Not Cardiovascular Disease, among HIV-Infected Adults.
A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.
Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection.
Quantitative evaluation of an instrument to identify chronic pain in HIV-infected individuals.
Short communication: Viral suppression is associated with increased likelihood of colorectal cancer screening among persons living with HIV/AIDS.
The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV+ African Americans.
A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).
Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.
LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults.
Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in Urban Zambia.
Short communication: Plasmacytoid dendritic cells from HIV-1 elite controllers maintain a gut-homing phenotype associated with immune activation.
Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function.
Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern United States.
Short communication: Lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States.
Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomes.
Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: Role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.
Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-Infected Zambian children.
Maraviroc observational study: The impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced patients.
Short communication: New HIV infections at southern new england academic institutions: Implications for prevention.
Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV Type 1-infected subjects over 48 weeks.
Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania.
Short communication routine HIV testing in the emergency department: Assessment of patient perceptions.
Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.
Cystatin C and baseline renal function among HIV-infected persons in the SUN study.
The role of toxicity-related regimen changes in the development of antiretroviral resistance.
Identification of three immunologic correlates for HIV type 1 pathogenesis in Youth.
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
Darunavir outcomes study: Comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks.
Erratum: Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174 (AIDS Research and Human Retroviruses (2010) 26 (425-432)).
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: Results of ACTG A5174.
Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: The impact on viral load suppression.
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults..
Short-term discontinuation of HAART regimens more common in vulnerable patient populations.
Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.
Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.
An open-label safety study of enfuvirtide injection with a needle-free injection device or needle/syringe: The Biojector 2000 open-label safety study (BOSS).
Solution structure of a calmodulin-binding domain in the carboxy-terminal region of HIV type 1 gp160.
Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
The complexity of circulating HIV type 1 strains in Oyo State, Nigeria.
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: Implications for drug resistance and host response.
Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: Week 60 results from the PACTG 381 cohort.
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.
Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy.
Sustained HIV viral suppression following treatment interruption: An observational study.
Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature.
Predictors of HIV serostatus among HIV discordant couples in Lusaka, Zambia and female antenatal clinic attendants in Kigali, Rwanda.
Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients.
Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
AZT enhances osteoclastogenesis and bone loss.
Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic.
Erratum: CD8+ CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ cell loss in a predominantly minority female HIV+ adolescent population (AIDS Research and Human Retroviruses (2004) 22 (263-269)).
CD8+CD88+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV + adolescent population.
Development of a novel human immunodeficiency virus type 1 subtyping tool, subtype analyzer (STAR): Analysis of subtype distribution in London.
HLA Allele Sharing and HIV Type 1 Viremia in Seroconverting Zambians with Known Transmitting Partners.
HIV Protease Inhibitor Ritonavir Induces Lipoatrophy in Male Mice.
T Cell Responses in HIV Type 1-Infected Adolescent Minorities Share Similar Epitope Specificities with Whites Despite Significant Differences in HLA Class I Alleles.
Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: In vitro expression and immune responses in DNA-vaccinated mice.
CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.
The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.
Detection of mucosal antibodies in HIV type 1-infected individuals.
HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I.
Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.
CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: Limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.
Position paper on therapeutic drug monitoring of antiretroviral agents.
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.
Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.
Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
HIV type 1 protease cleavage site mutations and viral fitness: Implications for drug susceptibility phenotyping assays.
Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis.
Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents.
False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens.
Induction of immune responses to SIV antigens by mucosally administered vaccines.
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals.
MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates.
HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.
HIV- 1(MN) recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1(MN) recombinant glycoprotein 120 vaccine.
The changing face of AIDS research and human retroviruses: A new forum to display your ART-work.
Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation.
Effects of tapering doses of oral prednisone on viral load among HIV- infected patients with unexplained weight loss.
A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers.
Characterization of the expression and immunogenicity of poliovirus replicons that encode Simian immunodeficiency virus SIV(mac)239 gag or envelope SU proteins.
Analysis of West African hunters for foamy virus infections.
HIV-specific cellular and humoral immune responses in primary HIV infection.
Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma.
Polyclonal Rabbit Antisera that Detect the Vpr Protein of SIVSM and SIVMAC on Immunoblots of Purified Virions.
Mucosal immunity in the female genital tract: Relevance to vaccination efforts against the human immunodeficiency virus.
CHARACTERIZATION OF VIRGIN AND MEMORY TYPE IFN-GAMMA PRODUCING CD8(+) T-LYMPHOCYTES IN SIV-INFECTED RHESUS MACAQUES.
Conference on advances in AIDS vaccine development - 1993 summary: Cytotoxic T-cell immunity workshop.
Conference on advances in AIDS vaccine development - 1993 summary: Mucosal immunity workshop.
Evolving Understanding of the Immunopathogenesis of HIV.
HIV-1 Sequence Subtype D in the United States.
New approaches for mucosal vaccines for AIDS: Encapsidation and serial passage of poliovirus replicons that express HIV-1 proteins on infection.
MUCOSAL VACCINE FOR AIDS - ORAL IMMUNIZATION WITH HIV GP120 IN COMBINATION WITH LIPOSOME AND CHOLERA-TOXIN INDUCES ANTIGEN-SPECIFIC IGA PRODUCING CELLS.
Isotype of anti-SIV responses in infected rhesus macaques and in animals immunized by mucosal routes.